G. Liberi

Paclitaxel and Docetaxel Stimulation of Doxorubicinol Formation in the Human Heart: Implications for Cardiotoxicity of Doxorubicin-Taxane Chemotherapies

L. Gianni, G. Minotti, P. Menna, 2006, Journal of Pharmacology and Experimental Therapeutics.

Paradoxical inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin. Pharmacologic and molecular reappraisal of anthracycline cardiotoxicity.

C. Mancuso, G. Minotti, S. Santini, 1996, The Journal of clinical investigation.

Defective One- or Two-electron Reduction of the Anticancer Anthracycline Epirubicin in Human Heart

L. Gianni, G. Minotti, P. Menna, 2006, Journal of Biological Chemistry.

Anthracycline metabolism and toxicity in human myocardium: comparisons between doxorubicin, epirubicin, and a novel disaccharide analogue with a reduced level of formation and [4Fe-4S] reactivity of its secondary alcohol metabolite.

C. Maggi, A. Cipollone, S. Manzini, 2000, Chemical research in toxicology.

The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein‐1 in cytosolic fractions from human myocardium

C. Mancuso, G. Minotti, G. Cairo, 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Doxorubicin-dependent reduction of ferrylmyoglobin and inhibition of lipid peroxidation: Implications for cardiotoxicity of anticancer anthracyclines

G. Minotti, P. Menna, E. Salvatorelli, 2002 .